Efficacy, tolerability and management of raltitrexed (Tomudex&unknown;) monotherapy in patients with advanced colorectal cancer - a review of phase II/III trials

Author： Cunningham D.   Zalcberg J.   Maroun J.   James R.   Clarke S.   Maughan T.S.   Vincent M.   Schulz J.   Gonzalez Baron M.   Facchini T.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.38, Iss.4, 2002-03, pp. : 478-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

By  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1133-1133

Oxford University Press

Access to resources Recommend Favorite

Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex ( R)) in advanced colorectal cancer

By Farrugia D.C.   Norman A.R.   Cunningham D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 987-991

Elsevier

Access to resources Recommend Favorite

'Tomudex' (ZD1694): Results of a Randomised Trial in Advanced Colorectal Cancer Demonstrate Efficacy and Reduced Mucositis and Leucopenia

By Cunningham D.   Zalcberg J.R.   Rath U.   Olver I.   Van Cutsem E.   Svensson C.   Seitz J.F.   Harper P.   Kerr D.   Perez-Manga G.   Azab M.   Seymour L.   Lowery K.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1945-1954

Elsevier

Access to resources Recommend Favorite

Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer

By                      

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1135-1139

Spandidos Publications

Access to resources Recommend Favorite

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer - a randomised phase II-III trial of the EORTC Gastrointestinal Group

By Wils J.   Blijham G.H.   Wagener T.   De Greve J.   Jansen R.L.H.   Kok T.C.   Nortier J.W.R.   Bleiberg H.   Couvreur M.L.   Genicot B.   Baron B.   on behalf of the EORTC Gastrointestinal Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 346-352

Elsevier

Access to resources Recommend Favorite